Impact of ABO-incompatibility on hepatic artery thrombosis in living donor liver transplantation

BACKGROUND: The current era of rituximab-based regimens brought improved survival in ABO-incompatible (ABO-I) living donor liver transplantation (LDLT). Nevertheless, the actual risk for hepatic artery thrombosis (HAT) still remains to be investigated. The aim of this study was to evaluate the impac...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ann Transl Med
Autors principals: Kim, Seong Hoon, Park, Jangho, Park, Sang Jae
Format: Artigo
Idioma:Inglês
Publicat: AME Publishing Company 2019
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6944632/
https://ncbi.nlm.nih.gov/pubmed/31930026
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2019.11.34
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars